Drug Approval | March 11, 2025
The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data
Biopharma and CROs to benefit from simplified access to global research sites
The business is a recognized leader in managing Covid-19 and mRNA research programs
The implementation of ScienceMedia's solutions will ultimately help AMCR collapse patient recruitment and enrollment
The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials
G42 Healthcare and AstraZeneca will work closely together to explore real-world evidence and conduct clinical trials through IROS – the first-of-its-kind Contract Research Organization (CRO) in the UAE
The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders
As part of this strategic partnership, LTI with its digital, technical and life sciences domain capabilities, will help accelerate joint go-to-market pursuits and faster deployment for Clinpal Adopters
Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on.
Subscribe To Our Newsletter & Stay Updated
